Simon Lowry Selected Research

Simon Lowry Research Topics

4	Psoriasis (Pustulosis Palmaris et Plantaris) 03/2022 - 12/2020
1	COVID-19 01/2022
1	Pneumonia (Pneumonitis) 01/2022
1	Hypoxia (Hypoxemia) 01/2022
1	Inflammation (Inflammations) 01/2022
1	Infections 01/2021
1	Endocarditis 01/2021
1	Antithrombin III Deficiency 05/2014
1	Pre-Eclampsia (Preeclampsia) 06/2013
1	Cardiotoxicity 04/2008
1	Pain (Aches) 01/2008
1	Rheumatic Diseases (Rheumatism) 01/2008
1	Arthritis (Polyarthritis) 01/2008
1	Hip Osteoarthritis (Coxarthrosis) 01/2008

4	tildrakizumabIBA 03/2022 - 12/2020
2	secukinumabIBA 03/2022 - 11/2021
2	guselkumabIBA 03/2022 - 11/2021
2	Etanercept (Enbrel)FDA Link 03/2022 - 11/2021
2	Adalimumab (Humira)FDA Link 03/2022 - 11/2021
2	Ustekinumab (CNTO 1275)FDA Link 03/2022 - 11/2021
2	ixekizumabIBA 03/2022 - 11/2021
2	Monoclonal AntibodiesIBA 01/2022 - 12/2020
2	apremilastIBA 11/2021 - 12/2020
2	AntithrombinsIBA 05/2014 - 06/2013
1	gimsilumabIBA 01/2022
1	Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)IBA 01/2022
1	Certolizumab Pegol FDA Link 11/2021
1	risankizumabIBA 11/2021
1	Daptomycin FDA Link 01/2021
1	Immunoglobulin G (IgG)IBA 12/2020
1	Thrombin FDA Link 05/2014
1	Sunitinib (Sutent)FDA Link 04/2008
1	Diclofenac (SR 38)FDA LinkGeneric 01/2008
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2008
1	Analgesics (Analgesic Drugs)IBA 01/2008
1	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2008
1	Celecoxib (Celebrex)FDA Link 01/2008